
Synergy Shield Coronary Stent 2.50 X 8 | REF H7493966608250
Boston Scientific Synergy Shield Coronary Stent, 2.50 mm x 8 mm (REF H7493966608250) for B2B medical device procurement.

The Terumo Ultimaster Nagomi Coronary Stent (REF DE-RS2218ASM) is a sirolimus-eluting coronary stent system pre-mounted on a rapid exchange delivery catheter, configured at 2.25 mm diameter x 18 mm length. It is designed to combine a thin-strut cobalt chromium platform with an abluminal bioresorbable polymer coating intended to release sirolimus during the early healing phase. This listing is intended for qualified B2B medical device procurement and hospital supply channels.
Key Features
- Drug: Sirolimus, eluted from an abluminal bioresorbable PDLLA-PCL polymer matrix
- Stent platform: Thin-strut cobalt chromium alloy with open-cell design
- Size: 2.25 mm x 18 mm (small-vessel configuration)
- Delivery system: Rapid exchange (Rx) monorail catheter compatible with 0.014" guidewires
- Guide catheter compatibility: Minimum 5F
- Sterility: Sterile, single-use, ethylene oxide sterilized
- Packaging: Individually packaged, pre-mounted on balloon delivery catheter
Clinical Applications
- Percutaneous coronary intervention (PCI) procedures performed in cardiac catheterization laboratories
- Treatment of de novo coronary artery lesions in small-caliber native coronary vessels, in line with the manufacturer Instructions for Use
- Hospital and cath lab inventory replenishment for interventional cardiology programs
- Group purchasing organization and distributor supply for cardiovascular device portfolios
Product Information
- Brand: Terumo
- Product line: Ultimaster Nagomi
- Category: Coronary Stents (Drug-Eluting)
- REF / UPN: DE-RS2218ASM
- Nominal stent diameter: 2.25 mm
- Nominal stent length: 18 mm
- Working length of delivery catheter: Not specified in the located sources
- Shelf life and storage: Refer to product label and Instructions for Use
- Regulatory status, indications, contraindications and warnings: Refer to the official Terumo Instructions for Use applicable to the destination market. Buyers are responsible for confirming local regulatory clearance prior to purchase and use.
Tell us what product you need and share a few details.
We connect your request with the most relevant verified brands.
Relevant supplier options can respond with availability, documentation context, and quote details.
Practical answers for procurement teams reviewing this product page.
Include the exact product family, brand preference, REF/UPN code when available, required quantity, destination country, expected delivery timing and documentation expectations.
Yes. If alternatives are acceptable, mention equivalent brands, compatible models, size ranges and any non-negotiable requirements.
Related products are connected through structured catalog data such as brand, category, product family and country assignment.
No. This page supports sourcing and RFQ organization. Buyers must verify regulatory status, clinical suitability and procurement compliance independently.
Specific codes reduce ambiguity and help supplier teams identify product availability, packaging details and documentation faster.
Yes. The workflow is designed for hospitals, clinics, distributors, wholesalers, importers and procurement departments.
Yes. Products can be connected to multiple countries in the admin panel, and buyers can specify destination details in the RFQ form.
The request is stored with contact and procurement details so the sourcing conversation can be reviewed and followed up clearly.